FDA Clears AI Software for Automated Contouring in Radiation Oncology

Geared toward enhanced efficiency for radiation oncologists, the MIM Contour ProtégéAI+ 2.0 software has garnered 510(k) clearance from the Food and Drug Administration (FDA).

Offering AI-enabled automated contouring, MIM Contour ProtégéAI+ 2.0 features new contouring models for brain MRI and pelvic computed tomography (CT) scans for men, according to GE HealthCare, the manufacturer of the software.

“Our technology is designed with the realities of our customers in mind,” said J. Anders, the general manager of MIM at GE HealthCare. “By automating one of the most time-intensive steps in radiation therapy planning, MIM Contour ProtégéAI+ 2.0 can help reduce treatment planning time and enable care teams to focus on refining treatment plans tailored to each patient’s needs.”

GE HealthCare said the FDA clearance for the MIM Contour ProtégéAI+ 2.0 software also includes a Predetermined Change Control Plan (PCCP), which facilitates future updates and enhancements to the modality.